Home > Search Clinical Trials > Hormone
Clinical Trials: Hormone
IRB No. 24-132-2 (Dr. Tarunya Vedere, PI): Primary Hyperaldosteronism is a Risk Factor for Developing Hypertensive Disorders of Pregnancy
This study is divided into 2 groups: study and control. The study group includes patients with a diagnosis of high blood pressure before, during or immediately after pregnancy [hypertensive disorder of pregnancy (HDP)] and the control group includes patients who do not have a diagnosis of high blood pressure around the time of pregnancy. This research is being done to determine if underlying excessive aldosterone hormone production [Primary Hyperaldosteronism (PA)] is a pre-pregnancy risk factor for HDP. HDP complicates about 10% of pregnancies and can cause a lifetime risk of developing chronic hypertension and cardiovascular disease (also called heart disease). PA occurs due to a problem of the adrenal glands (located on top of both kidneys) and is an underdiagnosed cause of hypertension (high blood pressure). Hyperaldosteronism happens when the adrenal glands release too much aldosterone hormone, leading to sodium retention, high blood pressure and low potassium levels. In this study, the researchers will assess if women with history of HDP have higher production of aldosterone compared to women without history of HDP. This will be done by testing blood and urine samples.
IRB No. 24-186-1 (Dr. Francesco Celi, PI): Novel approaches to the treatment of hypothyroidism
The study’s goal is to closely examine this phenomenon and help patients reduce their body weight, serum cholesterol, and improve their quality of life. Eligible study participants are those who are 18 and over and on stable thyroid replacement therapy. They will receive free outpatient care for hypothyroidism, study medications, and thyroid hormone and cholesterol lipid analyses for the duration of the study.